These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 31048789)

  • 101. Inside-Out of Complement in Cancer.
    Kolev M; Das M; Gerber M; Baver S; Deschatelets P; Markiewski MM
    Front Immunol; 2022; 13():931273. PubMed ID: 35860237
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Complement: The Road Less Traveled.
    Kemper C; Ferreira VP; Paz JT; Holers VM; Lionakis MS; Alexander JJ
    J Immunol; 2023 Jan; 210(2):119-125. PubMed ID: 36596217
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The role of the complosome in health and disease.
    Xiao F; Guo J; Tomlinson S; Yuan G; He S
    Front Immunol; 2023; 14():1146167. PubMed ID: 36969185
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Analysis of the Complement System in the Clinical Immunology Laboratory.
    Ling M; Murali M
    Clin Lab Med; 2019 Dec; 39(4):579-590. PubMed ID: 31668271
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Clinical promise of next-generation complement therapeutics.
    Mastellos DC; Ricklin D; Lambris JD
    Nat Rev Drug Discov; 2019 Sep; 18(9):707-729. PubMed ID: 31324874
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Toll-like Receptors and the Control of Immunity.
    Fitzgerald KA; Kagan JC
    Cell; 2020 Mar; 180(6):1044-1066. PubMed ID: 32164908
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Complement as a target in COVID-19?
    Risitano AM; Mastellos DC; Huber-Lang M; Yancopoulou D; Garlanda C; Ciceri F; Lambris JD
    Nat Rev Immunol; 2020 Jun; 20(6):343-344. PubMed ID: 32327719
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Complement, infection, and autoimmunity.
    Conigliaro P; Triggianese P; Ballanti E; Perricone C; Perricone R; Chimenti MS
    Curr Opin Rheumatol; 2019 Sep; 31(5):532-541. PubMed ID: 31192812
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Context-dependent roles of complement in cancer.
    Roumenina LT; Daugan MV; Petitprez F; Sautès-Fridman C; Fridman WH
    Nat Rev Cancer; 2019 Dec; 19(12):698-715. PubMed ID: 31666715
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Complement in neurological disorders and emerging complement-targeted therapeutics.
    Dalakas MC; Alexopoulos H; Spaeth PJ
    Nat Rev Neurol; 2020 Nov; 16(11):601-617. PubMed ID: 33005040
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Rationale for targeting complement in COVID-19.
    Polycarpou A; Howard M; Farrar CA; Greenlaw R; Fanelli G; Wallis R; Klavinskis LS; Sacks S
    EMBO Mol Med; 2020 Aug; 12(8):e12642. PubMed ID: 32559343
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.
    Defendi F; Thielens NM; Clavarino G; Cesbron JY; Dumestre-Pérard C
    Clin Rev Allergy Immunol; 2020 Apr; 58(2):229-251. PubMed ID: 31834594
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The complement system in COVID-19: friend and foe?
    Java A; Apicelli AJ; Liszewski MK; Coler-Reilly A; Atkinson JP; Kim AH; Kulkarni HS
    JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32554923
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The case of complement activation in COVID-19 multiorgan impact.
    Noris M; Benigni A; Remuzzi G
    Kidney Int; 2020 Aug; 98(2):314-322. PubMed ID: 32461141
    [TBL] [Abstract][Full Text] [Related]  

  • 115. COVID-19: A collision of complement, coagulation and inflammatory pathways.
    Chauhan AJ; Wiffen LJ; Brown TP
    J Thromb Haemost; 2020 Sep; 18(9):2110-2117. PubMed ID: 32608159
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Antibody-mediated complement activation in pathology and protection.
    Goldberg BS; Ackerman ME
    Immunol Cell Biol; 2020 Apr; 98(4):305-317. PubMed ID: 32142167
    [TBL] [Abstract][Full Text] [Related]  

  • 117. The complement system in schizophrenia: where are we now and what's next?
    Woo JJ; Pouget JG; Zai CC; Kennedy JL
    Mol Psychiatry; 2020 Jan; 25(1):114-130. PubMed ID: 31439935
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Targeting the complement system in bacterial meningitis.
    Koelman DLH; Brouwer MC; van de Beek D
    Brain; 2019 Nov; 142(11):3325-3337. PubMed ID: 31373605
    [TBL] [Abstract][Full Text] [Related]  

  • 119. The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1)
    Ghebrehiwet B; Geisbrecht BV; Xu X; Savitt AG; Peerschke EIB
    Semin Immunol; 2019 Oct; 45():101338. PubMed ID: 31744753
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Myeloid-derived suppressor cells-new and exciting players in lung cancer.
    Yang Z; Guo J; Weng L; Tang W; Jin S; Ma W
    J Hematol Oncol; 2020 Jan; 13(1):10. PubMed ID: 32005273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.